Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 187

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 187
---
$— $— $— $(5)$(5)Year ended December 31, 2023Beginning balance at January 1, 2023$137 $— $356 $88 $581 Total gains (losses):Recognized in net income(10)— — (4)(14)Recognized in accumulated other comprehensive income6 — 3 — 9 Purchases38 — 191 15 244 Sales(88)— (17)(21)(126)Settlements(21)— — — (21)Transfers into Level III6 2 6 — 14 Transfers out of Level III(22)— — — (22)Ending balance at December 31, 2023$46 $2 $539 $78 $665 Change in unrealized gains or losses included in net income related to assets still held at December 31, 2023$— $— $— $(6)$(6)Year ended December 31, 2022Beginning balance at January 1, 2022$336 $5 $19 $89 $449 Total gains (losses):Recognized in net income— — (1)— (1)Recognized in accumulated other comprehensive income(1)— (16)— (17)Purchases56 — 370 17 443 Sales(210)— (14)(18)(242)Settlements(41)— — — (41)Transfers into Level III9 — — — 9 Transfers out of Level III(12)(5)(2)— (19)Ending balance at December 31, 2022$137 $— $356 $88 $581 Change in unrealized gains or losses included in net income related to assets still held at December 31, 2022$— $— $— $— $— There were no individually material transfers into or out of Level III during the years ended December 31, 2024, 2023 or 2022.Certain assets and liabilities are measured at fair value on a nonrecurring basis; that is, the instruments are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances. As disclosed in Note 3,